Kittell B L, Helinski D R
Department of Biology, University of California, San Diego, La Jolla 92093-0634.
Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1389-93. doi: 10.1073/pnas.88.4.1389.
The broad-host-range plasmid RK2 and its derivatives are maintained in Gram-negative bacteria at a specific copy number that appears to be determined by a series of direct repeats (iterons) located at the RK2 replication origin and by the RK2 replication initiation protein. TrfA. An in vitro replication system was developed from Escherichia coli that is active with either the intact eight-iteron RK2 origin or a minimal five-iteron RK2 origin when purified TrfA protein is provided. Using this in vitro replication system, we have examined the mechanism(s) of copy-number control. It was found that two or more RK2 iterons present on a supercoiled compatible plasmid molecule are capable of specifically inhibiting in vitro the replication of either functional RK2 origin plasmid and that this inhibition is not overcome by adding increasing amounts of TrfA protein. A mutant TrfA protein, TrfA-33(cop254D), that increases the copy number of an RK2 origin in vivo exhibits replication kinetics and activity levels in this in vitro system similar to that of the wild-type protein. However, RK2 in vitro replication initiated by TrfA-33(cop254D) has a much reduced sensitivity to iteron inhibition. These data support a model for RK2 copy-number control that involves intermolecular coupling between TrfA-bound iterons.
广宿主质粒RK2及其衍生物在革兰氏阴性菌中以特定拷贝数维持,该拷贝数似乎由位于RK2复制起点的一系列直接重复序列(迭代子)以及RK2复制起始蛋白TrfA决定。构建了一种来自大肠杆菌的体外复制系统,当提供纯化的TrfA蛋白时,该系统对完整的八迭代子RK2起点或最小的五迭代子RK2起点均有活性。利用该体外复制系统,我们研究了拷贝数控制的机制。结果发现,超螺旋相容质粒分子上存在的两个或更多RK2迭代子能够在体外特异性抑制功能性RK2起点质粒的复制,并且增加TrfA蛋白的量并不能克服这种抑制作用。一种在体内增加RK2起点拷贝数的突变TrfA蛋白TrfA-33(cop254D),在该体外系统中表现出与野生型蛋白相似的复制动力学和活性水平。然而,由TrfA-33(cop254D)启动的RK2体外复制对迭代子抑制的敏感性大大降低。这些数据支持了一种RK2拷贝数控制模型,该模型涉及TrfA结合的迭代子之间的分子间偶联。